Motif Bio Plc Net Cash Flow 2015-2020 | MTFB

Motif Bio Plc net cash flow from 2015 to 2020. Net cash flow can be defined as the total change in cash for the company over the given period.

Motif Bio Plc Net Cash Flow 2015-2020 | MTFB

Motif Bio Plc net cash flow from 2015 to 2020. Net cash flow can be defined as the total change in cash for the company over the given period.
Related Stocks
Company NameMarket
Cap
AstraZeneca (AZN)$228.1B
Amgen (AMGN)$155.2B
Gilead Sciences (GILD)$148.5B
Vertex Pharmaceuticals (VRTX)$94B
Bristol Myers Squibb (BMY)$93.5B
CSL (CSLLY)$82.7B
GSK (GSK)$77.1B
Regeneron Pharmaceuticals (REGN)$60.8B
Alnylam Pharmaceuticals (ALNY)$57.5B
Argenex SE (ARGX)$40.5B
BioNTech SE (BNTX)$26.8B
Royalty Pharma (RPRX)$21.1B
Insmed (INSM)$20.8B
Biogen (BIIB)$19.2B
Incyte (INCY)$15.3B
Illumina (ILMN)$14.5B
Genmab (GNMSF)$14.3B
Genmab (GMAB)$13.7B
Ascendis Pharma (ASND)$11.7B
BioMarin Pharmaceutical (BMRN)$11B
QIAGEN (QGEN)$10.7B
Swedish Orphan Biovitrum (BIOVF)$10.6B
Moderna (MRNA)$10.2B
Exelixis (EXEL)$10.2B
Verona Pharma American Depositary Share (VRNA)$9B
Blueprint Medicines (BPMC)$8.3B
Bio-Techne Corp (TECH)$7.9B
Roivant Sciences (ROIV)$7.8B
Exact Sciences (EXAS)$7.8B
Halozyme Therapeutics (HALO)$7.8B